172 related articles for article (PubMed ID: 20234342)
1. AAV vectors avoid inflammatory signals necessary to render transduced hepatocyte targets for destructive T cells.
Somanathan S; Breous E; Bell P; Wilson JM
Mol Ther; 2010 May; 18(5):977-82. PubMed ID: 20234342
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells.
Zhang Y; Chirmule N; Gao Gp; Wilson J
J Virol; 2000 Sep; 74(17):8003-10. PubMed ID: 10933709
[TBL] [Abstract][Full Text] [Related]
3. Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicity.
Martino AT; Nayak S; Hoffman BE; Cooper M; Liao G; Markusic DM; Byrne BJ; Terhorst C; Herzog RW
PLoS One; 2009 Aug; 4(8):e6376. PubMed ID: 19652717
[TBL] [Abstract][Full Text] [Related]
4. Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes.
Li H; Murphy SL; Giles-Davis W; Edmonson S; Xiang Z; Li Y; Lasaro MO; High KA; Ertl HC
Mol Ther; 2007 Apr; 15(4):792-800. PubMed ID: 17245353
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic immune response after retroviral-mediated hepatic gene transfer in rat does not preclude expression from adeno-associated virus 1 transduced muscles.
Aubert D; Pichard V; Durand S; Moullier P; Ferry N
Hum Gene Ther; 2003 Mar; 14(5):473-81. PubMed ID: 12691612
[TBL] [Abstract][Full Text] [Related]
6. Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells.
Martino AT; Basner-Tschakarjan E; Markusic DM; Finn JD; Hinderer C; Zhou S; Ostrov DA; Srivastava A; Ertl HC; Terhorst C; High KA; Mingozzi F; Herzog RW
Blood; 2013 Mar; 121(12):2224-33. PubMed ID: 23325831
[TBL] [Abstract][Full Text] [Related]
7. Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets.
Wang L; Figueredo J; Calcedo R; Lin J; Wilson JM
Hum Gene Ther; 2007 Mar; 18(3):185-94. PubMed ID: 17324107
[TBL] [Abstract][Full Text] [Related]
8. The Balance between CD8
Kumar SRP; Hoffman BE; Terhorst C; de Jong YP; Herzog RW
Mol Ther; 2017 Apr; 25(4):880-891. PubMed ID: 28284982
[TBL] [Abstract][Full Text] [Related]
9. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers.
Jooss K; Yang Y; Fisher KJ; Wilson JM
J Virol; 1998 May; 72(5):4212-23. PubMed ID: 9557710
[TBL] [Abstract][Full Text] [Related]
10. lacZ transgenic rats tolerant for beta-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene.
Ménoret S; Aubert D; Tesson L; Braudeau C; Pichard V; Ferry N; Anegon I
Hum Gene Ther; 2002 Jul; 13(11):1383-90. PubMed ID: 12162820
[TBL] [Abstract][Full Text] [Related]
11. AAV8 induces tolerance in murine muscle as a result of poor APC transduction, T cell exhaustion, and minimal MHCI upregulation on target cells.
Mays LE; Wang L; Lin J; Bell P; Crawford A; Wherry EJ; Wilson JM
Mol Ther; 2014 Jan; 22(1):28-41. PubMed ID: 23778424
[TBL] [Abstract][Full Text] [Related]
12. Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction.
Miao CH; Nakai H; Thompson AR; Storm TA; Chiu W; Snyder RO; Kay MA
J Virol; 2000 Apr; 74(8):3793-803. PubMed ID: 10729154
[TBL] [Abstract][Full Text] [Related]
13. The Effect of CpG Sequences on Capsid-Specific CD8
Xiang Z; Kurupati RK; Li Y; Kuranda K; Zhou X; Mingozzi F; High KA; Ertl HCJ
Mol Ther; 2020 Mar; 28(3):771-783. PubMed ID: 31839483
[TBL] [Abstract][Full Text] [Related]
14. A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction.
Nakai H; Thomas CE; Storm TA; Fuess S; Powell S; Wright JF; Kay MA
J Virol; 2002 Nov; 76(22):11343-9. PubMed ID: 12388694
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to AAV in clinical trials.
Mingozzi F; High KA
Curr Gene Ther; 2011 Aug; 11(4):321-30. PubMed ID: 21557723
[TBL] [Abstract][Full Text] [Related]
16. Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer.
Chirmule N; Moscioni AD; Qian Y; Qian R; Chen Y; Wilson JM
Hum Gene Ther; 1999 Jan; 10(2):259-69. PubMed ID: 10022550
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo.
Li C; Hirsch M; DiPrimio N; Asokan A; Goudy K; Tisch R; Samulski RJ
J Virol; 2009 Jul; 83(13):6817-24. PubMed ID: 19369348
[TBL] [Abstract][Full Text] [Related]
18. Effect of CpG Depletion of Vector Genome on CD8
Bertolini TB; Shirley JL; Zolotukhin I; Li X; Kaisho T; Xiao W; Kumar SRP; Herzog RW
Front Immunol; 2021; 12():672449. PubMed ID: 34135899
[TBL] [Abstract][Full Text] [Related]
19. Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy.
Ghazizadeh S; Kalish RS; Taichman LB
Mol Ther; 2003 Mar; 7(3):296-303. PubMed ID: 12668125
[TBL] [Abstract][Full Text] [Related]
20. Recombinant AAV-transduced iris pigment epithelial cell transplantation may transfer vector to native RPE but suppress systemic dissemination.
Yoshioka Y; Abe T; Wakusawa R; Moriya T; Mochizuki S; Saigo Y; Saito T; Murata H; Tokita Y; Iseya T; Sugano E; Tomita H; Sagara Y; Tamai M
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):745-52. PubMed ID: 16431976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
